PROTOX, a subsidiary of DSK, announced on December 1 that it has signed an exclusive 10-year supply agreement with the Spanish aesthetics company Mesoestetic. The contract covers the supply of PROTOX’s independently developed botulinum …

November 17, 2025 – SEOUL, South Korea — PROTOX Inc. announced that it has officially obtained marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its botulinum toxin product, Protoxin Injection. …

Protox’s botulinum toxin preparation ‘Protoxin Inj. (tentative name)’ is speeding up commercialization. It has applied for approval in Korea and was approved for phase 3 in Russia. The analysis is that Protox’s two-track commercialization strategy at …

Protox was selected as the best among institutions with excellent biological security management as a result of ‘regular (occasional) inspection of biological agents, etc.’ over the past three years and received the Minister of …

Protox, a company specializing in manufacturing botulinum toxin drugs, announced on the 17th that it has signed an exclusive supply contract between Brazil and Russia for its own botulinum toxin type A (tentative name …

Protox, a DSK subsidiary, announced on the 20th that it has received IRB (Clinical Research Review Committee) approval from Pusan National University Hospital for phase 3 clinical trials of botulinum toxin type A “Protoxin”. …

Protox’s botulinum toxin A formulation ‘Protoxin’ will soon enter phase 3 clinical trials. The Ministry of Food and Drug Safety submitted a report submitted by Protox on the 1st, titled ‘Multicenter, double-blind, random allocation …

Protox, a biopharmaceutical affiliate of Synergy Partners Group, announced on the 3rd that it will successfully end phase 1 clinical trial of its own botulinum toxin type A, “Protoxin” and begin phase 2 clinical …

Protox received permission to export Protoxin. According to the Ministry of Food and Drug Safety’s Integrated Drug Information System, product approval was granted for export of Protox ‘Protoxin Injection 100 Units (Clostridium Botulinum Toxin …

Protox, a biopharmaceutical company, announced on the 3rd that it has obtained clinical plan approval and GMP approval for Protoxin, a botulinum toxin drug, from the Ministry of Food and Drug Safety, as of …